Genomic Health, Inc. (GHDX) Tops Q3 EPS by 6c, Sales Fall Inline
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Research and development: 46.4M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
Research and development: 46.4M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Genomic Health, Inc. (NASDAQ: GHDX) reported Q3 EPS of $0.10, $0.06 better than the analyst estimate of $0.04. Revenue for the quarter came in at $52.1 million versus the consensus estimate of $52.3 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- Dollar Tree (DLTR) Tops Q2 EPS by $1.59, Beats on Revenue; Offers FY Guidance
- Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
